Остеопороз у больных бронхиальной астмой

1. Насонов Е.Л., Скрипников И.А., Насонова В.А. Проблема остеопороза в ревматологии.— М.: Стин, 1997.

2. Чучалин А.Г., Берова М.М. Функциональное состояние кальцийрегулирующей системы у больных бронхиальной астмой / / Клин мед.— 1989.— Т.67, № 8.— С.56—59.

3. Adachi J.D., Bensen W.G., Bianchi F. et al. Vitamin D and calcium in the prevention of corticosteroid induced osteoporosis: a 3 year follow-up / / J. Rheumatol.— 1996.— Vol.23, № 6.— P.995—1000.

4. Balsan S., Steru D., Bourdeau A. et al. Effects of long-term maintenance therapy with a new glucocorticoid, deflazacort, on mineral metabolism and statural growth / / Calcif. Tissue int.— 1987.— Vol.40, № 6.— P.303—309.

5. Barnes N.C. Safety of high-dose inhaled corticosteroids / / Respir. Med.— 1993.— Vol.87.— Suppl.A.— P.27—31.

6. Binz K., Schmid C., Bouillon R. et al. Interactions of insulin-like growth factor I with dexamethasone on trabecular bone density and mineral metabolism in rats / / Eur. J. Endocrinol.— 1994.— Vol. 130.— P.387—393.

7. Bootsma G.P., Deckhuijzen P.N.R., Festen J., van Herwaarden C.L.A. Effects of inhaled corticosteroids in asthma / / Allergy.— 1997.— Vol.52.— Suppl.39.— P .l—34.

8. Boutsen Y., Jamart J., Esselinckx W. et al. Primary prevention of glucocorticoid-induced osteoporosis with intermittent intravenous pamidronate: a randomized trial / / Calcif. Tissue int.— 1997.— Vol.61, № 4.— P.266—271.

9. Brandli D.W., Golde G., Greenwald M ., Silverm an S.L. Glucocorticoid-induced osteoporosis: a cross-sectional study / / Steroids.— 1991.— Vol.56, № 10.— P.518—523.

10. Delany A.M., Dong Y., Canalis E. Mechanisms of glucocorticoid action in bone cells / / J. Cell Biochem.— 1994.— Vol.56, № 3.— P.295—302.

11. Delany A.M., Gabbitas B.Y., Canalis E. Cortisol downregulates osteoblast alpha 1 (I) procollagen mRNA by transcriptional and posttranscriptional mechanisms / / Ibid.— 1995.— Vol.57, № 3.— P.488—494.

12. Delmas P., Seeman E., Liunghall S. et al. Alendronate in postmenopausal and glucocorticoid-induced osteoporosis / / Osteoporos. intern.— 1998.— Vol.8.— Suppl.3.— P.133.

13. Diamond T., M cGuigan L., Barbagallo S., Bryant C. Cyclic etidronate plus ergocalciferol prevents glucocorticoid-induced bone loss in postmenopausal women / / Amer. J. Med.— 1995.— Vol.98, № 5.— P.459—463.

14. Eastell R., Reid D M ., Compston J. et al. A UK Consensus Group on management of glucocorticoid-induced osteoporosis: an update / / J. intern. Med.— 1998.— Vol.244.— P.271—292.

15. Fabbri L.M., Piattela M., Caramori G., LiacciaA. Oral vs inhaled asthma therapy. Proc, cons and combinations / / Drugs.— 1996.— Vol.52.— Suppl.6.— P.20—28.

16. Gennari C. Differential effect of glucocorticoids on calcium absorbtion and bone mass / / Brit. J. Rheumatol.— 1993.— Vol.32.— Suppl.2.— P.l1—14.

17. Gronowicz G.A., M cCarthy M .B. Glucocorticoid inhibit the attachment of osteoblasts to bone extracellular matrix proteins and decrease beta 1 -integrin levels / / Endocrinology.— 1995.— Vol. 136, № 2.— P.598—608.

18. Guaydier-Souquieres G., Kotzki P.O., Sabatier J.P. et al. In corticosteroid-treaterd respiratory diseases, monofluorophosphate increases lumbar bone density: a double-masked randomized study / / Osteoporos. intern.— 1996.— Vol.6, № 2.— P.171—177.

19. Gulko P.S., M ulloy A.L. Glucocorticoid-induced ostoporosis: pathogenesis, prevention and treatment / / Clin. exp. Rheumatol.— 1996.— Vol.14, No 2.— P.199—206.

20. Hanania N.A., Chapman K.R., Kesten S. Adverse effects of inhaled corticosteroids / / Amer. J. Med.— 1995.— Vol.98.— P. 196—204.

21. Herrala Puolijoki H., Imprivaara O. et al. Bone mineral density in asthmatic women on high-dose inhaled beclomethasone dipropionate / / Bone.— 1994.— Vol. 15, № 6.— P.621—623.

22. Herrala J., Puolijoki H., Liippo K. et al. Clodronate is effective in preventing corticosteroid induced bone loss among asthmatic patients / / Ibid.— 1998.— Vol.22, № 5.— P.577—582.

23. Lacronique J. Primum non nocere: inhaled corticoids / / Rev. Pneumol. Clin.— 1996.— Vol.52, № 2.— P.137—143.

24. Laroche M., Porteau L., Caron P. et al. Osteoporotic vertebral fractures in man under high-dose inhaled glucocorticoid therapy. A case-report with a review of the literature / / Rev. Rhum. Engl. Ed.— 1997.— Vol.64, № 4.— P.267—270.

25. Ledford D., Apter A., Brenner A.M . et al. Osteoporosis in the corticosteroid-treated patient with asthma / / J. Allergy clin. Immunol.— 1998.— Vol.102, № 3.— P.353—362.

26. Luengo M., Picado C., Del Rio L. et al. Treatment of steroid-induced osteopenia with calcitonin in corticosteroid-dependent asthma / / Amer. Rev. respir. Dis.— Vol. 142.— P. 104—107.

27. Luengo M., Picado C., Del Rio L. et al. Vertebral fractures in steroid dependent asthma and involutional osteoporosis: a comparative study / / Thorax.— 1991.— Vol.46, № 11.— P.803—806.

28. Luengo M., Picado C., Piera C. et al. Intestinal calcium absorbtion and parathyroid hormone secretion in asthmatic patients on prolonged oral or inhaled steroid treatment / / Eur. Respir. J.— 1991.— Vol.4, № 4.— P.441—444.

29. Luengo M., Pons F.t M artinez de Osaba M.J., Picado C. Prevention of futher bone loss by nasal calcitonin in patients on long term glucocorticoid therapy for asthma: a two year follow up study / / Thorax.— 1994.— Vol.49, N2 11.— P.1099—1102.

30. Lukert B.P., Raisz L.G. Glucocorticoid-induced osteoporosis: pathogenesis and management / / Ann. intern. Med.— 1990.— Vol. 112, N2 5.— P.352—364.

31. Lukert B.P., Johnson B.E., Robinson R.G. Estrogen and progesterone replacement therapy reduced glucocorticoid-induced bone loss / / J. Bone Miner. Res.— 1992.— Vol.7.— P. 1063—1069.

32. M acAdams M.R., White R.H., Chipps B.E. Reduction of serum testosterone levels during chronic glucocorticoid therapy / / Ann. intern. Med.— 1986.— Vol.104.— P.648—651.

33. M arkham A., Bryson H.M. Deflazacort. A review of its pharmacological properties and therapeutic efficacy / / Drugs.— 1995.— Vol.50, № 2.— P.317—333.

34. McLeod J.F. Osteoporosis, cytokines, and glucocorticoids / / Allergy Proc.— 1993.— Vol. 14, N2 5.— P.363—364.

35. Morrison N.A., Shine J., Verkest V. et at. 1,25-Dihydroxyvitamin D responsive element and glucocorticoid repression in the osteocalcin gene / / Science.— 1989.— Vol.246.— P. 1158—1161.

36. M yers J.R., Sherman C.B. Should supplemental estrogens be used as steroid-sparing agents in asthmatic women? / / Chest.— 1994.— Vol.106, No 1.— P.318—319.

37. Peretz A., Praet J.R., Bosson D. et al. Serum osteocalcin in the assesment of corticosteroid induced osteoporosis. Effect of long and short term corticosteroid treatment / / J. Rheumatol.— 1989.— Vol. 16, No 3.— P.363—367.

38. Picado C., Luengo M. Corticosteroid-induced bone-loss. Prevention and management / / Drug Saf.— 1996.— Vol.15, N2 5.— P.347—359.

39. Reid I.R. Glucocorticoid osteoporosis - mechanisms ana management / / Eur. J. Endocrinol.— 1997.— Vol. 137, № 3.— P.209— 217.

40. Reid I.R., Ibbertson H.K. Evidence for decreased tubular reabsorption of calcium in glucocoricoid-treated asthmatic / / Horm. Res.— 1987.— Vol.27, N2 4.— P.200—204.

41. Reid I.R., W attie D.J., Evans M.C., Stapleton J.P. Testosterone therapy in glucocorticoid-treated men / / Arch, intern. Med.— 1996.— Vol. 156, № 11.— P. 1173—1177.

42. Sambrook P., Birmingham J., Kelly P. et al. Prevention of corticosteroid osteoporosis / / New Engl. J. Med.— 1993.— Vol.328, No 24.— P.1747—1752.

43. Schatz M., Dudl J., Zeiger R.S. et al. Osteoporosis in corticosteroid-treated asthmatic patients: clinical correlates / / Allergy Proc.— 1993.— Vol.14, No 5.— P.341—345.

44. Scutt A., Bertram P., Bräutigam M. The role of glucocorticoids and prostaglandin E2 in the recruitment of bone marrow mesenchimal cells to the osteoblastic lineage: positive and negative effects / / Calcif. Tissue int.— 1996.— Vol.59, № 3.— P. 154—162.

45. Sebaldt R.J., Adachi S.D., Bensen W.G. et al. Intermittent cyclic therapy with etidronate prevents cortocosteroid-induced bone loss: two years of follow-up / / Scand. J. Rheumatol.— 1996.— Suppl.103.— P.91—93.

46. Smith B.J., Buxton J.R., Dickeson J., Heller R.F. Does beclomethasone dipropionate supress dehydroepiandrosterone sulphate in postmenopausal women? / / Aust. N. Z. J. Med.— 1994.— Vol.24, No 4.— P.396—401.

47. Toogood J.H., Jennings B., Hodsman A.B. et al. Effects of dose and dosing schedule of inhaled budesonide on bone turnover / / J. Allergy clin. Immunol.— 1991.— Vol.88, № 4.— P.572—580.

48. Walsh L.J., Tattersfield A.E. Bone disease in asthma / / Brit. J. hosp. Med.— 1997.— Vol.57, № 8.— P.390—393.

49. Ward M.J. Inhaled corticosteroids - effect on bone? / / Respir. Med.— 1993.— Vol.87.— Suppl.A.— P.33—35.

50. Wisniewski A.F., Lewis S., Maslanka W.B. et al. A cross-sectional study of the effects of inhaled steroids on bone density and bone metabolism in patients with asthma / / Amer. J. Respir. Crit. Care Med.— 1995.— Vol. 151.— P.A 374.

51. Worth H., Stammen D., Keck E. Therapy of steroid-induced loss in adult asthmatics with calcium, vitamin D, and a diphosphonate / / Ibid.— 1994.— Vol. 150, N2 2.— P.394—397.

52. Yamada H. Long-term effect of 1 alpha-hydroxyvitamin D, calcium and thiazide administration on glucocorticoid-induced osteoporosis / / Nippon Naibunpi Gakkai Zasshi.— 1989.— Vol.65, № 6.— P.603—614.